Investor Presentation H1 2023

27 Investor presentation First six months of 2023 Sales growth of 30%, driven by both NAO and IO with 44% and 17% sales growth respectively Historic and reported sales by geography Reported sales and growth breakdown for the first six months of 2023 Novo NordiskⓇ Total in DKK billion 111.8 177.0 107.7 Regions Sales (mDKK) Growth Share of growth 9% 14% 13% 10% International Operations 48,707 17% 29% 9% 8% EMEA 25,598 19% 16% 30% 24% 25% Region China 8,928 12% 4% ROW 14,181 18% 9% North America Operations 58,960 44% 71% 51% 52% 55% Hereof USA 54,531 42% 63% Total sales 107,667 30% 100% 2018 2022 H1 2023 North America EMEA Region China ROW Source: Quarterly company announcement IO: International Operations; NAO: North American Operations; EMEA: Europe, Middle East, and Africa; RoW: Rest of World; Region China covers mainland China, Hong Kong and Taiwan Note: Numbers may not add up to 100% due to rounding; Growth at Constant exchange rates; Sales numbers are reported in Danish kroner

View entire presentation